

Hyalohyphomycosis and phaeohyphomycosis were associated with substantial mortality. Culture-based diagnosis often takes weeks for growth and identification of the causative organism, often leading to inappropriate antifungal treatment while awaiting specific results. Innovation in non-culture-based diagnostics could help improve patient outcomes.
Regional Health – Americas
|11th Mar, 2026
|The Lancet
Regional Health – Americas
|11th Mar, 2026
|The Lancet
Regional Health – Americas
|11th Mar, 2026
|The Lancet
Regional Health – Americas
|11th Mar, 2026
|The Lancet
Regional Health – Americas
|11th Mar, 2026
|The Lancet
Regional Health – Americas
|11th Mar, 2026
|The Lancet
Regional Health – Americas
|11th Mar, 2026
|The Lancet